Remedy Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch Remedy Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion (NCT03954041) | Remedy Pharmaceuticals, Inc. | 2019-10-06 |
| Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (NCT02864953) | Remedy Pharmaceuticals, Inc. | 2018-08-29 |
Track Remedy Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.